Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret(®)) in systemic juvenile idiopathic arthritis

por Livermore, P, Woo, P
Publicado 2008

CS15.3 More and more coronaviruses after the SARS epidemic: human coronavirus HKU1 and other coronaviruses

por Woo, P.C.Y.
Publicado 2011

I-58 More and more human and animal coronaviruses

por Woo, P.C.Y.
Publicado 2008

Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre

por Livermore, P, Woodworth, T, Woo, P
Publicado 2008

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept

por Livermore, P, Woo, P, Wedderburn, LR
Publicado 2008

Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment

por Ogilvie, EM, Samuel, JM, Woo, P
Publicado 2008

Are genetic variants of Caspase-1 and Cryopyrin associated with systemic JIA?

por Stock, CJ, Ogilvie, EM, Samuel, JM, Fife, M, Woo, P
Publicado 2008

Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study

por Mulligan, K, Etheridge, A, Kassoumeri, L, Woo, P, Wedderburn, LR, Newman, S
Publicado 2008

PW01-038 – Genomewide association study of Still’s disease

por Ombrello, MJ, Remmers, EF, Zeggini, E, Thomson, W, Kastner, DL, Woo, P
Publicado 2013

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

por Ombrello, M, Remmers, E, Zeggini, E, Thomson, W, Kastner, D, Woo, P
Publicado 2015

Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age–period–cohort approach

por Woo, P P S, Thach, T Q, Choy, S T B, McGhee, S M, Leung, G M
Publicado 2005

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth...

por Hirani, SP, Kassoumeri, L, Mulligan, K, Ruperto, N, Woo, P, Wedderburn, LR, Newman, SP
Publicado 2008

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

por Hirani, SP, Kassoumeri, L, Etheridge, A, Mulligan, K, Ruperto, N, Woo, P, Wedderburn, L, Newman, SP
Publicado 2008

PW02-031 - Genetic and clinical manifestations of CAPS

por Bybee, AK, Lachmann, H, Omoyinmi, E, Nedjai, B, Woo, P, Lane, T, Savic, S, Hawkins, P, McDermott, M
Publicado 2013

Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia

por Woo, P. C. Y., Lau, S. K. P., Huang, Y., Tsoi, H.-W., Chan, K.-H., Yuen, K.-Y.
Publicado 2005

Human rhinovirus C: a newly discovered human rhinovirus species

por LauLau, S K P, SK, YipYip, C C Y, CC, WooWoo, P C Y, PC, Yuen, K-Y
Publicado 2010

UK paediatric rheumatology and its clinical trials network

por Beresford, MW, Baildam, EM, Brogan, PA, Foster, HE, Ramanan, AV, Rooney, ME, Shah, UU, Thomson, W, Wedderburn, LR, Woo, P
Publicado 2008

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J...

por Ruperto, N, Quartier, P, Wulffraat, N, Woo, P, Loy, A, Mouy, R, Bader-Meunier, B, Prakken, B, Noseda, E, Rordorf, C
Publicado 2008

Loss of function mutation in a mitochondrial chaperone protein leading to dyregulated ROS production, and autoinflammatory disease in a single kindred

por Standing, A, Eleftheriou, D, Paisan-Ruiz, C, Rowcenzio, D, Hong, Y, Omoyinmi, E, Woo, P, Hawkins, P, Lachmann, H, Klein, N, Brogan, P
Publicado 2015

Primary infective spondylodiscitis caused by Lactococcus garvieae and a review of human L. garvieae infections

por Chan, J. F. W., Woo, P. C. Y., Teng, J. L. L., Lau, S. K. P., Leung, S. S. M., Tam, F. C. C., Yuen, K.-Y.
Publicado 2011